Solvotrin Therapeutics Biographies

Solvotrin Therapeutics was founded by Pat O’Flynn, Dr John Gilmer and Dr Mark Ledwidge.

Pat O’Flynn
Pat is an entrepreneur with a proven business track record of over fifteen years experience, including the Pharmachem industry. Pat was previously CEO of AVR-Safeway Limited, a company which he co-founded and in which he created significant shareholder value. The company was sold to international utility company Veolia in 2008. Pat has successfully managed joint ventures and collaborations with leading international companies. Pat was a finalist in the 2008 Ernst and Young Entrepreneur of the Year Award. He holds academic qualifications in Mechtronic Engineering, Business Management, Corporate Finance and Leadership.

Dr. Mark Ledwidge
Mark is a pharmacist with a PhD in pharmaceutics from TCD. He has over 16 years experience in pharmaceutical marketing and translational cardiovascular research. He is also a founder of The Heartbeat Trust and Pharmacy Prime Limited.

Dr. John Gilmer
John is a lecturer at the School of Pharmacy and Pharmaceutical Sciences at TCD. He is a scientist with over 20 years of experience. He is a world leader in prodrug technology and an expert in cancer cell platelet interactions and pharmaceutical intellectual property.